Virginia Aiassa

818 total citations
43 papers, 647 citations indexed

About

Virginia Aiassa is a scholar working on Molecular Biology, Pharmaceutical Science and Biomedical Engineering. According to data from OpenAlex, Virginia Aiassa has authored 43 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Pharmaceutical Science and 14 papers in Biomedical Engineering. Recurrent topics in Virginia Aiassa's work include Drug Solubulity and Delivery Systems (14 papers), Nanoplatforms for cancer theranostics (10 papers) and Photodynamic Therapy Research Studies (10 papers). Virginia Aiassa is often cited by papers focused on Drug Solubulity and Delivery Systems (14 papers), Nanoplatforms for cancer theranostics (10 papers) and Photodynamic Therapy Research Studies (10 papers). Virginia Aiassa collaborates with scholars based in Argentina, Brazil and Germany. Virginia Aiassa's co-authors include Marcela R. Longhi, Ariana Zoppi, Inés Albesa, Claudia Garnero, M. C. Becerra, Sol R. Martínez, Cecilia I. Álvarez Igarzabal, Daniel A. Heredia, Mario A. Quevedo and Andrés M. Durantini and has published in prestigious journals such as Biochemical and Biophysical Research Communications, ACS Applied Materials & Interfaces and Carbohydrate Polymers.

In The Last Decade

Virginia Aiassa

41 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia Aiassa Argentina 16 202 176 161 127 88 43 647
Prakash Khadka New Zealand 10 455 2.3× 224 1.3× 156 1.0× 103 0.8× 98 1.1× 24 986
Gabriel Lima Barros de Araújo Brazil 17 275 1.4× 157 0.9× 156 1.0× 82 0.6× 61 0.7× 59 849
Maria Malamatari United Kingdom 10 427 2.1× 354 2.0× 148 0.9× 88 0.7× 60 0.7× 15 924
Hany S.M. Ali Egypt 12 428 2.1× 120 0.7× 93 0.6× 146 1.1× 46 0.5× 27 737
Alpana A. Thorat United States 9 179 0.9× 216 1.2× 128 0.8× 114 0.9× 55 0.6× 14 691
Gyiae Yun South Korea 8 441 2.2× 212 1.2× 145 0.9× 95 0.7× 89 1.0× 12 894
Susana Torrado Spain 16 259 1.3× 153 0.9× 112 0.7× 143 1.1× 54 0.6× 25 786
Ahmad Salawi Saudi Arabia 17 253 1.3× 127 0.7× 154 1.0× 113 0.9× 30 0.3× 55 782
Mihir Raval India 18 498 2.5× 186 1.1× 147 0.9× 69 0.5× 63 0.7× 43 875
María Cristina Martínez-Ohárriz Spain 17 335 1.7× 173 1.0× 118 0.7× 67 0.5× 88 1.0× 36 670

Countries citing papers authored by Virginia Aiassa

Since Specialization
Citations

This map shows the geographic impact of Virginia Aiassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Aiassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Aiassa more than expected).

Fields of papers citing papers by Virginia Aiassa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Aiassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Aiassa. The network helps show where Virginia Aiassa may publish in the future.

Co-authorship network of co-authors of Virginia Aiassa

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Aiassa. A scholar is included among the top collaborators of Virginia Aiassa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Aiassa. Virginia Aiassa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villarreal, Miguel, et al.. (2025). Exploring Riboflavin Derivatives in the Photodynamic Inactivation of Staphylococcus aureus. ChemPhotoChem. 9(11).
2.
Zoppi, Ariana, et al.. (2025). Carrier-free cholesteric liquid crystal and xerogel of clarithromycin-ascorbic acid with enhanced antimicrobial and antibiofilm activity. International Journal of Pharmaceutics. 685. 126255–126255.
3.
Aiassa, Virginia, et al.. (2024). Exploring Efavirenz supramolecular complexes to reduce Staphylococcus aureus virulence and resistance factors. Journal of Drug Delivery Science and Technology. 104. 106524–106524. 1 indexed citations
4.
Martínez, Sol R., et al.. (2024). Light-activated conjugated polymer nanoparticles to defeat pathogens associated with bovine mastitis. Journal of Photochemistry and Photobiology B Biology. 257. 112971–112971. 4 indexed citations
5.
6.
Aiassa, Virginia, Claudia Garnero, Ariana Zoppi, & Marcela R. Longhi. (2023). Cyclodextrins and Their Derivatives as Drug Stability Modifiers. Pharmaceuticals. 16(8). 1074–1074. 46 indexed citations
7.
Aiassa, Virginia, et al.. (2023). Polymeric micelles as a strategy to enhance the phototoxic efficacy of phenazine photosensitizers. Polymers for Advanced Technologies. 34(11). 3397–3406. 2 indexed citations
8.
Aiassa, Virginia, et al.. (2023). Development and Characterization of Pharmaceutical Systems Containing Rifampicin. Pharmaceutics. 15(1). 198–198. 8 indexed citations
9.
Chattah, Ana K., et al.. (2020). Exploring solid forms of oxytetracycline hydrochloride. International Journal of Pharmaceutics. 585. 119496–119496. 11 indexed citations
10.
Martínez, Sol R., Virginia Aiassa, Claudia Sola, & M. C. Becerra. (2020). Oxidative stress response in reference and clinical Staphylococcus aureus strains under Linezolid exposure. Journal of Global Antimicrobial Resistance. 22. 257–262. 12 indexed citations
11.
Aiassa, Virginia, et al.. (2019). Nanostructured Gold Coating for Prevention of Biofilm Development in Medical Devices. Journal of Endourology. 34(3). 345–351. 13 indexed citations
12.
Aiassa, Virginia, et al.. (2019). Evaluation of physicochemical properties and bacterial photoinactivation of phenothiazine photosensitizers. Photochemical & Photobiological Sciences. 18(6). 1576–1586. 14 indexed citations
13.
Aiassa, Virginia, Ariana Zoppi, M. C. Becerra, Inés Albesa, & Marcela R. Longhi. (2016). Enhanced inhibition of bacterial biofilm formation and reduced leukocyte toxicity by chloramphenicol:β-cyclodextrin:N-acetylcysteine complex. Carbohydrate Polymers. 152. 672–678. 36 indexed citations
14.
Aiassa, Virginia, Ariana Zoppi, Inés Albesa, & Marcela R. Longhi. (2014). Inclusion complexes of chloramphenicol with β-cyclodextrin and aminoacids as a way to increase drug solubility and modulate ROS production. Carbohydrate Polymers. 121. 320–327. 47 indexed citations
15.
Zoppi, Ariana, et al.. (2013). Binding of Sulfamethazine to β-cyclodextrin and Methyl-β-cyclodextrin. AAPS PharmSciTech. 14(2). 727–735. 20 indexed citations
16.
Garnero, Claudia, Virginia Aiassa, & Marcela R. Longhi. (2012). Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization. Journal of Pharmaceutical and Biomedical Analysis. 63. 74–79. 48 indexed citations
17.
Aiassa, Virginia, et al.. (2011). Sublethal ciprofloxacin treatment leads to resistance via antioxidant systems in Proteus mirabilis. FEMS Microbiology Letters. 327(1). 25–32. 14 indexed citations
18.
Aiassa, Virginia, et al.. (2010). Increased advanced oxidation of protein products and enhanced total antioxidant capacity in plasma by action of toxins of Escherichia coli STEC. Toxicology in Vitro. 25(1). 426–431. 16 indexed citations
19.
Aiassa, Virginia, et al.. (2010). Resistance to ciprofloxacin by enhancement of antioxidant defenses in biofilm and planktonic Proteus mirabilis. Biochemical and Biophysical Research Communications. 393(1). 84–88. 38 indexed citations
20.
Cuffini, Silvia Lucía, Javier Ellena, Yvonne Primerano Mascarenhas, et al.. (2007). Physicochemical characterization of deflazacort: Thermal analysis, crystallographic and spectroscopic study. Steroids. 72(3). 261–269. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prakash Khadka Breakdown of academic impact, for papers by Gabriel Lima Barros de Araújo Breakdown of academic impact, for papers by Maria Malamatari Breakdown of academic impact, for papers by Hany S.M. Ali Breakdown of academic impact, for papers by Alpana A. Thorat Breakdown of academic impact, for papers by Gyiae Yun Breakdown of academic impact, for papers by Susana Torrado Breakdown of academic impact, for papers by Ahmad Salawi Breakdown of academic impact, for papers by Mihir Raval Breakdown of academic impact, for papers by María Cristina Martínez-Ohárriz
Rankless by CCL
2026